We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Pledges to Launch Pilot Programs Focused on Rare Diseases in its PDUFA VII Commitment Letter
FDA Pledges to Launch Pilot Programs Focused on Rare Diseases in its PDUFA VII Commitment Letter
Within its commitment letter for the upcoming reauthorization of the Prescription Drug User Fee Amendments (PDUFA), the FDA and the pharmaceutical industry have agreed to collaborate closely on pilot programs for rare diseases.